Factors Associated with Diabetes Control in Predominately African American and Hispanic Population with Newly Diagnosed Type 2 Diabetes.
Adult
Black or African American
/ psychology
Blood Glucose Self-Monitoring
/ statistics & numerical data
Diabetes Mellitus, Type 2
/ diagnosis
Female
Glycated Hemoglobin
/ analysis
Glycemic Control
/ statistics & numerical data
Hispanic or Latino
/ psychology
Humans
Hypoglycemic Agents
/ therapeutic use
Insulin
/ therapeutic use
Longitudinal Studies
Male
Medication Adherence
/ ethnology
Middle Aged
Retrospective Studies
Self-Management
/ psychology
Diabetes self-management
Glycemic control
HbA1c target
Newly diagnosed diabetes
Type 2 diabetes
Journal
Journal of racial and ethnic health disparities
ISSN: 2196-8837
Titre abrégé: J Racial Ethn Health Disparities
Pays: Switzerland
ID NLM: 101628476
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
03
01
2020
accepted:
26
05
2020
revised:
26
05
2020
pubmed:
20
6
2020
medline:
20
11
2021
entrez:
20
6
2020
Statut:
ppublish
Résumé
This study characterizes factors affecting glycemic control in a predominately African American and Hispanic population with newly diagnosed type 2 diabetes (T2DM). Retrospective longitudinal cohort study of 1638 patients with newly diagnosed T2DM to determine factors associated with improved HbA At baseline, mean age 51.7 ± 11.5 years, males 52.9%, mean BMI 33.9 ± 7.8 kg/m In those with newly diagnosed T2DM, achieving better glycemic control was mainly related to patient self-management behaviors and inversely related to insulin use. Emphasis on patients' diabetes education and empowerment are critical to improved glycemic control.
Sections du résumé
BACKGROUND
This study characterizes factors affecting glycemic control in a predominately African American and Hispanic population with newly diagnosed type 2 diabetes (T2DM).
METHODS
Retrospective longitudinal cohort study of 1638 patients with newly diagnosed T2DM to determine factors associated with improved HbA
RESULTS
At baseline, mean age 51.7 ± 11.5 years, males 52.9%, mean BMI 33.9 ± 7.8 kg/m
CONCLUSIONS
In those with newly diagnosed T2DM, achieving better glycemic control was mainly related to patient self-management behaviors and inversely related to insulin use. Emphasis on patients' diabetes education and empowerment are critical to improved glycemic control.
Identifiants
pubmed: 32557276
doi: 10.1007/s40615-020-00785-9
pii: 10.1007/s40615-020-00785-9
doi:
Substances chimiques
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
332-338Références
Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2017. Atlanta: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, et al. The Oregon experiment—effects of Medicaid on clinical outcomes. N Engl J Med. 2013;368:1713–22.
doi: 10.1056/NEJMsa1212321
Berkowitz SA, Meigs JB, DeWalt D, Seligman HK, Barnard LS, Bright OJM, et al. Material need insecurities, control of diabetes mellitus, and use of health care resources: results of the Measuring Economic Insecurity in Diabetes study. JAMA Intern Med. 2015;175:257–65.
doi: 10.1001/jamainternmed.2014.6888
Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an Endocrine Society scientific statement. JCEM. 2012;97:E1579.
doi: 10.1210/jc.2012-2043
Philis-Tsimikas A, Walker C. Improved care for diabetes in underserved populations. J Ambul Care Manage. 2001;24:39–43.
doi: 10.1097/00004479-200101000-00005
Morkos M, Tahsin B, Fogg L, Fogelfeld L. Newly diagnosed type 2 diabetes in an ethnic minority population: clinical presentation and comparison to other populations. BMJ Open Diabetes Res Care. 2018 Oct 11;6(1):e000568.
doi: 10.1136/bmjdrc-2018-000568
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.
doi: 10.1016/S0140-6736(98)07019-6
Diabetes Control and Complications Trial Research Group, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
doi: 10.1056/NEJM199309303291401
Action to Control Cardiovascular Risk in Diabetes Study Group, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.
doi: 10.1056/NEJMoa0802743
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.
doi: 10.1056/NEJMoa0808431
Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9.
doi: 10.1016/S0140-6736(09)61969-3
Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2008;358(24):2630–3.
doi: 10.1056/NEJMe0804182
American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Suppl 1):S61–70.
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Suppl 1):S13–28.
doi: 10.2337/dc19-S002
Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29:587–94.
doi: 10.1016/S1262-3636(07)70073-3
Norris SL, Engelgau MM, Narayan KV. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24:561–87.
doi: 10.2337/diacare.24.3.561
Berikai P, Meyer PM, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients' knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care. 2007;30:1587–9.
doi: 10.2337/dc06-2026
Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17–20.
doi: 10.2337/diacare.27.1.17
El-Kebbi IM, Cook CB, Ziemer DC, et al. Association of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetes. Arch Intern Med. 2003;163:69–75.
doi: 10.1001/archinte.163.1.69
Halban PA, Polonsky KS, Bowden DW, Hawkins MA, Ling C, Mather KJ, et al. β-Cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. JCEM. 2014;99(6):1983–92.
doi: 10.1210/jc.2014-1425